Coherus BioSciences【CHRS】株式ニュース

名称	銘柄コード	市場	種別
Coherus BioSciences Inc	CHRS	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.01	-0.57%	1.73	13:00:01

始値	安値	高値	終値	前日終値
1.72	1.68	1.75	1.69	1.74

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/06	07:57	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/06	07:55	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2024/6/06	07:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/06	07:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/06	07:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/06	07:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/06	07:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/06	07:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/05	22:11	EDGAR2	Form 8-K - Current report
2024/6/05	22:00	GLOBE	Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its..
2024/6/05	05:05	EDGAR2	Form 8-K - Current report
2024/5/30	22:00	GLOBE	Coherus Management to Present at the 2024 Jefferies Global..
2024/5/24	06:51	GLOBE	Coherus Presents Preliminary Results from Phase I Dose..
2024/5/23	22:00	GLOBE	Coherus Management to Present at the TD Cowen 5th Annual..
2024/5/22	06:14	EDGAR2	Form 8-K/A - Current report: [Amend]
2024/5/14	05:35	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
2024/5/10	05:51	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/10	05:17	EDGAR2	Form 8-K - Current report
2024/5/10	05:01	GLOBE	Coherus BioSciences Reports First Quarter 2024 Financial..
2024/5/09	20:30	EDGAR2	Form 8-K - Current report
2024/5/09	20:30	GLOBE	Coherus Announces Full Repayment of Pharmakon Advisors $75..
2024/5/08	22:00	GLOBE	Coherus Announces Clinical Collaboration with the Cancer..
2024/5/02	05:30	GLOBE	Coherus to Report First Quarter 2024 Financial Results on..
2024/4/24	23:02	GLOBE	Coherus Announces Presentation at the 2024 American Society..
2024/4/08	21:30	GLOBE	Coherus Presents Preclinical Data for CHS-1000, a Novel..
2024/3/14	05:01	GLOBE	Coherus BioSciences Reports Fourth Quarter, Full Year 2023..
2024/3/06	06:01	GLOBE	Coherus to Report Fourth Quarter and Full Year 2023..
2024/3/04	20:22	EDGAR2	Form 8-K - Current report
2024/3/04	15:00	GLOBE	Coherus Completes Divestiture of Ophthalmology Franchise
2024/2/24	07:33	GLOBE	Coherus BioSciences Announces New Employment Inducement..
2024/2/23	07:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/23	07:00	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2024/2/23	06:59	EDGAR2	Form 8-K - Current report
2024/2/21	22:30	GLOBE	Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and..
2024/2/05	22:09	EDGAR2	Form 8-K - Current report
2024/2/05	22:00	GLOBE	Coherus Amends Term Loan Agreement with Pharmakon Advisors,..
2024/1/24	10:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/24	10:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/22	22:01	EDGAR2	Form 8-K - Current report
2024/1/22	15:59	DJN	Sandoz to Acquire Cimerli Business from Coherus for $170..
2024/1/22	15:15	GLOBE	Coherus Announces Agreement to Divest Ophthalmology..
2024/1/19	06:05	GLOBE	Coherus Presents Positive Phase 2 Clinical Data on..
2024/1/10	11:41	EDGAR2	Form 8-K - Current report
2024/1/10	11:39	EDGAR2	Form 8-K - Current report
2024/1/10	09:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/09	08:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/05	07:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/05	07:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/04	22:00	PRNUS	INOVIO and Coherus Announce Clinical Collaboration to..
2024/1/04	06:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..